What is it about?
Our immune system includes roaming “hit-squad” cells called natural-killer (NK) cells. Their job is to latch onto suspicious cells like tumor cells and deliver a lethal blow. But cancer has a clever defense. As soon as an NK cell makes contact, the tumor cell rapidly drags inhibitory surface molecules, typically more abundant on healthy cells, into the small handshake zone where the immune cell docks. These molecules send a strong “stand down” signal that tells the NK cell not to attack. We discovered that tumor cells use their internal scaffolding, called actin filaments, as conveyor belts to move these “everything-is-fine” signals into position within minutes. When we blocked this actin-based transport, NK cells regained their killing power and successfully eliminated the cancer cells.
Featured Image
Photo by Jametlene Reskp on Unsplash
Why is it important?
Our findings contribute to resolving a long-standing puzzle: how tumors manage to evade both of the immune system’s main killers: T cells and NK cells. To escape T cells, tumors reduce the number of MHC-I molecules on their surface. These molecules normally act as display boards, presenting internal cell fragments that alert T cells to signs of abnormal activity. Lowering MHC-I helps the tumor stay hidden from T cells. But here’s the paradox: MHC-I molecules also serves as “don’t-kill-me” signals for NK cells. In theory, reducing MHC-I should make tumors more visible and more vulnerable to NK cells. Yet many MHC-I–low tumors manage to survive. Our study helps explain how. We found that as soon as an NK cell engages with a tumor, the cancer cell rapidly sweeps its few remaining MHC-I molecules into the narrow contact zone. This concentrated burst of inhibitory signals convinces the NK cell to stand down. By uncovering this immune evasion strategy, our study contributes to filling a key gap in understanding how tumors escape both T-cell and NK-cell surveillance. Recognizing this trick is a first step toward developing strategies that keep NK cells on the attack.
Perspectives
One of the most striking aspects of our findings is how quickly tumor cells react when faced with an NK cell. Within minutes, they reorganize actin filaments and shift key surface molecules into the contact zone to protect themselves. This shows that cancer cells can sense the immune attack and rapidly put up a shield, a localized defense that stops the NK cell from firing. What we don’t yet know is what triggers this reaction. What signals inside the tumor cell tell it to move these “don’t-kill-me” molecules into place the moment an NK cell arrives? Understanding this internal alarm system, and how it controls the movement of these inhibitory signals, will be essential. By uncovering these pathways, we hope to find new ways to block the tumor’s response. More importantly, this knowledge could help us design improved NK cells that don’t trigger this defensive maneuver in the first place. In the future, this could lead to therapies that keep NK cells active and effective, even against tumors that have learned to fight back.
Clément Thomas
Luxembourg Institute of Health
Read the Original
This page is a summary of: Cancer cells suppress NK cell activity by actin-driven polarization of inhibitory ligands to the immunological synapse, Proceedings of the National Academy of Sciences, August 2025, Proceedings of the National Academy of Sciences,
DOI: 10.1073/pnas.2503259122.
You can read the full text:
Contributors
The following have contributed to this page
